206 related articles for article (PubMed ID: 17020779)
1. Prognostic value of humbug gene overexpression in stage II colon cancer.
Wang J; de la Monte SM; Sabo E; Kethu S; Tavares R; Branda M; Simao L; Wands JR; Resnick MB
Hum Pathol; 2007 Jan; 38(1):17-25. PubMed ID: 17020779
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
Maeda T; Taguchi K; Aishima S; Shimada M; Hintz D; Larusso N; Gores G; Tsuneyoshi M; Sugimachi K; Wands JR; de la Monte SM
Cancer Detect Prev; 2004; 28(5):313-8. PubMed ID: 15542253
[TBL] [Abstract][Full Text] [Related]
3. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR
Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase/humbug expression in non-small cell lung carcinoma.
Luu M; Sabo E; de la Monte SM; Greaves W; Wang J; Tavares R; Simao L; Wands JR; Resnick MB; Wang L
Hum Pathol; 2009 May; 40(5):639-44. PubMed ID: 19200576
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of HAAH/humbug quantitative detection in the diagnosis of hepatocellular carcinoma.
Xue T; Su J; Li H; Xue X
Oncol Rep; 2015 Jan; 33(1):329-37. PubMed ID: 25394783
[TBL] [Abstract][Full Text] [Related]
6. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR
J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107
[TBL] [Abstract][Full Text] [Related]
7. Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells.
Lahousse SA; Carter JJ; Xu XJ; Wands JR; de la Monte SM
BMC Cell Biol; 2006 Dec; 7():41. PubMed ID: 17156427
[TBL] [Abstract][Full Text] [Related]
8. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
Kontos CK; Papadopoulos IN; Scorilas A
Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.
Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB
Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of humbug promotes malignant progression in human gastric cancer cells.
Lee JH
Oncol Rep; 2008 Mar; 19(3):795-800. PubMed ID: 18288418
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
[TBL] [Abstract][Full Text] [Related]
13. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging.
Jassam N; Bell SM; Speirs V; Quirke P
Oncol Rep; 2005 Jul; 14(1):17-21. PubMed ID: 15944762
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of human telomerase reverse transcriptase in patients with colon cancer].
Li LR; Wan DS; Pan ZZ; Hardingham J; Rieger N; Hewett P; Zhou ZW; Chen G
Ai Zheng; 2004 Nov; 23(11 Suppl):1502-7. PubMed ID: 15566667
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of fibroblast activation protein in patients with colon cancer.
Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer.
Kasahara M; Takahashi Y; Nagata T; Asai S; Eguchi T; Ishii Y; Fujii M; Ishikawa K
Clin Cancer Res; 2000 Jul; 6(7):2707-11. PubMed ID: 10914714
[TBL] [Abstract][Full Text] [Related]
17. Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer.
Papagerakis S; Shabana AH; Pollock BH; Papagerakis P; Depondt J; Berdal A
Hum Pathol; 2009 Sep; 40(9):1320-9. PubMed ID: 19386346
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Li M; Li JY; Zhao AL; Gu J
Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
[TBL] [Abstract][Full Text] [Related]
19. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
Poincloux L; Durando X; Seitz JF; Thivat E; Bardou VJ; Giovannini MH; Parriaux D; Barriere N; Giovannini M; Delpero JR; Monges G
Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome.
Wang K; Liu J; Yan ZL; Li J; Shi LH; Cong WM; Xia Y; Zou QF; Xi T; Shen F; Wang HY; Wu MC
Hepatology; 2010 Jul; 52(1):164-73. PubMed ID: 20578260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
